Primary Site >> Biliary tract Cancer

Gene >> SRC

  • 1995
  • 2000
  • 2001
  • 2004
  • 2013
  • 2015
  • 2016
  • 2017
Ref: Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
PMID: 7705949
Ref: Increased expression of N-myristoyltransferase in gallbladder carcinomas.
PMID: 10813869
Ref: Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype.
PMID: 11495044
Ref: Establishment and characterization of unique human gallbladder cancer cell lines.
PMID: 15067341
Ref: Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis.
PMID: 23315987
Ref: Protective Effects of Guava Pulp on Cholestatic Liver Injury.
PMID: 27335829
Ref: Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
PMID: 24839254
Ref: Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of beta-Catenin in Mice.
PMID: 26033745
Ref: FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
PMID: 27216177
Ref: Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.
PMID: 27231123
Ref: MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
PMID: 27825112
Ref: Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.
PMID: 28223426